|
|
DongKoo Bio & Pharma Co Ltd
KRX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 09/11/2026 15:30
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization97,487 mln
Earnings Date08/18/2025
P / E
3.01
Deeply undervalued
Key Fundamentals
EPS1,163
P/E3.01
ROE24.84
ROIC0.09
ROA10.84
Interest Cover0.09
EBITDA, mln55,029
EV / EBITDA3.03
EV / EBIT3.57
Revenue, mln241,434
EV / Revenue0.69
Financial Strength
Altman Z-Score1.97
Piotroski F-Score
5
/ 9
Beneish M-Score-2.18
Price to Intrinsic Value1.32
Shiller PE Ratio7.15
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-2.91% |
21
/ 100
 |
| 1 Month |
-11.95% |
14
/ 100
 |
| 2 Months |
-14.22% |
38
/ 100
 |
| 6 Months |
-36.25% |
18
/ 100
 |
| 1 Year |
-29.41% |
23
/ 100
|
|
| |
